Zymeworks Inc.
ZYME
$14.81
-$0.03-0.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 95.94% | 85.05% | 0.38% | -86.52% | -85.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 95.94% | 85.05% | 0.38% | -86.52% | -85.99% |
| Cost of Revenue | 18.60% | 7.18% | -4.43% | -26.85% | -30.71% |
| Gross Profit | 64.48% | 42.13% | 9.90% | -121.45% | -121.39% |
| SG&A Expenses | -2.03% | -9.51% | -12.69% | -31.16% | -26.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.52% | 1.38% | -7.16% | -28.31% | -29.38% |
| Operating Income | 32.00% | 26.96% | 11.33% | -160.16% | -165.16% |
| Income Before Tax | 41.86% | 16.18% | 2.21% | -153.55% | -157.96% |
| Income Tax Expenses | 280.20% | 445.46% | 1,171.13% | -128.72% | -124.74% |
| Earnings from Continuing Operations | 34.52% | 9.76% | -3.39% | -155.38% | -160.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.52% | 9.76% | -3.39% | -155.38% | -160.46% |
| EBIT | 32.00% | 26.96% | 11.33% | -160.16% | -165.16% |
| EBITDA | 35.57% | 28.73% | 11.07% | -153.75% | -157.85% |
| EPS Basic | 35.69% | 15.97% | 6.95% | -148.23% | -154.13% |
| Normalized Basic EPS | 34.43% | 33.76% | 22.97% | -140.84% | -145.37% |
| EPS Diluted | 35.74% | 16.09% | 7.23% | -148.57% | -154.57% |
| Normalized Diluted EPS | 34.41% | 33.79% | 23.00% | -140.88% | -145.43% |
| Average Basic Shares Outstanding | 2.48% | 6.13% | 10.16% | 10.50% | 10.11% |
| Average Diluted Shares Outstanding | 3.21% | 6.16% | 10.20% | 10.50% | 10.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |